Back to search

Plasmapheresis and immunosuppressive drug therapy in the Eaton‐Lambert syndrome

Data up to Jan 2025

Published1982
Citations85
References22

Total Citations Per Year

Abstract

References (22)

Antibody to acetylcholine receptor in myasthenia gravis

1998 • 1,149 citations

Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value

1976 • 1,123 citations

Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia Gravis

1977 • 396 citations

ELECTROMYOGRAPHY AND ELECTRIC STIMULATION OF NERVES IN DISEASES OF MOTOR UNIT

1957 • 341 citations

Plasmapheresis and the Immunobiology of Myasthenia Gravis

1979 • 168 citations

Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton‐Lambert syndrome

1978 • 159 citations

The effect of guanidine on neuromuscular transmission.

1960 • 118 citations

DEFECTS OF NEUROMUSCULAR TRANSMISSION IN SYNDROMES OTHER THAN MYASTHENIA GRAVIS

1966 • 108 citations

Plasmapheresis therapy in myasthenia gravis

1980 • 102 citations

The Eaton-Lambert syndrome and autoimmune disorders

1972 • 95 citations

Myasthenia and Malignant Intrathoracic Tumor

1960 • 83 citations

CLINICAL, NEUROPHYSIOLOGICAL AND MORPHOLOGICAL FINDINGS IN EATON LAMBERT SYNDROME

2009 • 55 citations

Cholinergic dysautonomia and Eaton‐Lambert syndrome

1979 • 48 citations

Guanidine and germine in Eaton‐Lambert syndrome

1976 • 45 citations

Eaton-Lambert Syndrome

1972 • 38 citations

Histometric study of neuromuscular junction ultrastructure

1972 • 27 citations

Guanidine treatment and impaired renal function in the Eaton-Lambert syndrome.

1977 • 24 citations

The influence of local cooling on neuromuscular transmission in the myasthenic syndrome of eaton and lambert

1977 • 16 citations

Neuromuscular blockade with anti‐axoplasmic antibodies

1977 • 15 citations

Autoimmune neuromuscular disease induced by a preparation of choline acetyltransferase

1982 • 8 citations

[Pharmacological effects of Roche mestinon: 1-methyl-3-(dimethylcarbamyloxypyridinium bromide); pyridostigmine bromide].

1953 • 4 citations

PLASMAPHERESIS AND IMMUNOSUPPRESSION IN THE MYASTHENIC SYNDROME: (LAMBERT‐EATON SYNDROME)

1981 • 4 citations

Cited By (0)

Loading...
Plasmapheresis and immunosuppressive drug therapy in the Eaton‐Lambert syndrome (1982) – Annals of Neurology | Metascience Observatory Explorer